Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Biotechniques ; 0(0): 1-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22668512

ABSTRACT

Members of the heat shock protein-90 (Hsp90) family are key regulators of biological processes through dynamic interaction with a multitude of protein partners. However, the transient nature of these interactions hinders the identification of Hsp90 interactors. Here we show that chemical cross-linking with ethylene glycolbis (succinimidylsuccinate), but not shorter cross-linkers, generated an abundant 240-kDa heteroconjugate of the molecular chaperone Hsp90 in different cell types. The combined use of pharmacological and genetic approaches allowed the characterization of the subunit composition and subcellular compartmentalization of the multimeric protein complex, termed p240. The in situ formation of p240 did not require the N-terminal domain or the ATPase activity of Hsp90. Utilizing subcellular fractionation techniques and a cell-impermeant cross-linker, subpopulations of p240 were found to be present in both the plasma membrane and the mitochondria. The Hsp90-interacting proteins, including Hsp70, p60Hop and the scaffolding protein filamin A, had no role in governing the formation of p240. Therefore, chemical cross-linking combined with proteomic methods has the potential to unravel the protein components of this p240 complex and, more importantly, may provide an approach to expand the range of tools available to the study of the Hsp90 interactome.

2.
Int J Biochem Cell Biol ; 42(11): 1856-63, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20692357

ABSTRACT

Adaptive responses to physical and inflammatory stressors are mediated by transcription factors and molecular chaperones. The transcription factor heat shock factor 1 (HSF1) has been implicated in extending lifespan in part by increasing expression of heat shock response genes. Pyrrolidine dithiocarbamate (PDTC) is a small thiol compound that exerts in vivo and in vitro anti-inflammatory properties through mechanisms that remain unclear. Here we report that PDTC induced the release of monomeric HSF1 from the molecular chaperone heat shock protein 90 (Hsp90), with concomitant increase in HSF1 trimer formation, translocation to the nucleus, and binding to promoter of target genes in human HepG2 cells. siRNA-mediated silencing of HSF1 blocked BAG3 gene expression by PDTC. The protein levels of the co-chaperone BAG3 and its interaction partner Hsp72 were stimulated by PDTC in a dose-dependent fashion, peaking at 6h. Inhibition of Hsp90 function by geldanamycin derivatives and novobiocin elicited a pattern of HSF1 activation and BAG3 expression that was similar to PDTC. Chromatin immunoprecipitation studies showed that PDTC and the inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin enhanced the binding of HSF1 to the promoter of several target genes, including BAG3, HSPA1A, HSPA1B, FKBP4, STIP1 and UBB. Cell treatment with PDTC increased significantly the level of Hsp90α thiol oxidation, a posttranslational modification known to inhibit its chaperone function. These results unravel a previously unrecognized mechanism by which PDTC and related compounds could confer cellular protection against inflammation through HSF1-induced expression of heat shock response genes.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , DNA-Binding Proteins/metabolism , Pyrrolidines/pharmacology , Thiocarbamates/pharmacology , Transcription Factors/metabolism , Adaptor Proteins, Signal Transducing/genetics , Apoptosis Regulatory Proteins , Benzoquinones/pharmacology , Blotting, Western , Chromatin Immunoprecipitation , DNA-Binding Proteins/genetics , HSP72 Heat-Shock Proteins , HSP90 Heat-Shock Proteins/metabolism , Heat Shock Transcription Factors , Hep G2 Cells , Humans , Lactams, Macrocyclic/pharmacology , Novobiocin/pharmacology , Polymerase Chain Reaction , Protein Binding/drug effects , RNA Interference , Transcription Factors/genetics , Tumor Cells, Cultured
3.
Endocrinology ; 150(6): 2551-60, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19213840

ABSTRACT

The actin-binding protein filamin A (FLNa) affects the intracellular trafficking of various classes of receptors and has a potential role in oncogenesis. However, it is unclear whether FLNa regulates the signaling capacity and/or down-regulation of the activated epidermal growth factor receptor (EGFR). Here it is shown that partial knockdown of FLNa gene expression blocked ligand-induced EGFR responses in metastatic human melanomas. To gain greater insights into the role of FLNa in EGFR activation and intracellular sorting, we used M2 melanoma cells that lack endogenous FLNa and a subclone in which human FLNa cDNA has been stably reintroduced (M2A7 cells). Both tyrosine phosphorylation and ubiquitination of EGFR were significantly lower in epidermal growth factor (EGF)-stimulated M2 cells when compared with M2A7 cells. Moreover, the lack of FLNa interfered with EGFR interaction with the ubiquitin ligase c-Cbl. M2 cells exhibited marked resistance to EGF-induced receptor degradation, which was very active in M2A7 cells. Despite comparable rates of EGF-mediated receptor endocytosis, internalized EGFR colocalized with the lysosomal marker lysosome-associated membrane protein-1 in M2A7 cells but not M2 cells, in which EGFR was found to be sequestered in large vesicles and subsequently accumulated in punctated perinuclear structures after EGF stimulation. These results suggest the requirement of FLNa for efficient EGFR kinase activation and the sorting of endocytosed receptors into the degradation pathway.


Subject(s)
Contractile Proteins/metabolism , ErbB Receptors/metabolism , Melanoma/metabolism , Microfilament Proteins/metabolism , Phosphotransferases/metabolism , Signal Transduction/physiology , Biopsy , Cell Line, Tumor , Contractile Proteins/genetics , DNA, Complementary/genetics , Down-Regulation/physiology , Endocytosis/physiology , Filamins , Humans , Lysosomes/metabolism , Melanoma/pathology , Microfilament Proteins/genetics , Proto-Oncogene Proteins c-cbl/metabolism , Transfection
4.
Endocrinology ; 150(3): 1122-31, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18988672

ABSTRACT

S-glutathionylation is a physiological, reversible protein modification of cysteine residues with glutathione in response to mild oxidative stress. Because the key cell growth regulator signal transducer and activator of transcription (STAT) 3 is particularly susceptible to redox regulation, we hypothesized that oxidative modification of cysteine residues of STAT3 by S-glutathionylation may occur. Herein, we show that the cysteine residues of STAT3 are modified by a thiol-alkylating agent and are the targets of S-glutathionylation. STAT3 protein thiol reactivity was reversibly attenuated with concomitant increase in the S-glutathionylation of STAT3 upon treatment of human HepG2 hepatoma cells with pyrrolidine dithiocarbamate, glutathione disulfide, or diamide. Under these conditions there was a marked reduction in IL-6-dependent STAT3 signaling, including decreased STAT3 tyrosine phosphorylation, loss in nuclear accumulation of STAT3, and impaired expression of target genes, such as fibrinogen-gamma. In a cell-free system, diamide induced glutathionylation of STAT3, which was decreased upon addition of glutaredoxin (GRX)-1, a deglutathionylation enzyme, or the reducing agent, dithiothreitol. Glutathionylated STAT3 was a poor Janus protein tyrosine kinase 2 substrate in vitro, and it exhibited low DNA-binding activity. Cellular GRX-1 activity was inhibited by diamide and pyrrolidine dithiocarbamate treatment; however, ectopic expression of GRX-1 was accompanied by a modest increase in phosphorylation, nuclear translocation, and DNA-binding ability of STAT3 in response to IL-6. These results are the first to show S-glutathionylation of STAT3, a modification that may exert regulatory function in STAT3 signaling.


Subject(s)
Glutathione/metabolism , Protein Processing, Post-Translational/physiology , STAT3 Transcription Factor/metabolism , Antioxidants/pharmacology , Cells, Cultured , Cysteine/metabolism , Diamines/pharmacology , Glutaredoxins/genetics , Glutaredoxins/metabolism , Glutaredoxins/physiology , Humans , Interleukin-6/pharmacology , Janus Kinase 2/metabolism , Oxidants/pharmacology , Phosphorylation , Protein Processing, Post-Translational/drug effects , Pyrrolidines/pharmacology , STAT3 Transcription Factor/physiology , Signal Transduction/physiology , Thiocarbamates/pharmacology , Transfection
5.
J Biol Chem ; 282(20): 14816-26, 2007 May 18.
Article in English | MEDLINE | ID: mdl-17389601

ABSTRACT

The actin-binding protein filamin A (FLNa) is associated with diverse cellular processes such as cell motility and signaling through its scaffolding properties. Here we examine the effect of FLNa on the regulation of signaling pathways that control the expression of matrix metalloproteinases (MMPs). The lack of FLNa in human M2 melanoma cells was associated with constitutive and phorbol ester-induced expression and secretion of active MMP-9 in the absence of MMP-2 up-regulation. M2 cells displayed stronger MMP-9 production and activity than their M2A7 counterparts where FLNa had been stably reintroduced. Using an MMP-9 promoter construct (pMMP-9-Luc), in vitro kinase assays, and genetic and pharmacological approaches, we demonstrate that FLNa mediated transcriptional down-regulation of pMMP-9-Luc by suppressing the constitutive hyperactivity of the Ras/MAPK extracellular signal-regulated kinase (ERK) cascade. Experimental evidence indicated that this phenomenon was associated with destabilization and ubiquitylation of Ras-GRF1, a guanine nucleotide exchange factor that activates H-Ras by facilitating the release of GDP. Ectopic expression of Ras-GRF1 was accompanied by ERK activation and elevated levels of MMP-9 in M2A7 cells, whereas a catalytically inactive dominant negative Ras-GRF1, which prevented ERK activation, reduced MMP-9 expression in M2 cells. Our results indicate that expression of FLNa regulates constitutive activation of the Ras/ERK pathway partly through a Ras-GRF1 mechanism to modulate the production of MMP-9.


Subject(s)
Contractile Proteins/biosynthesis , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , MAP Kinase Signaling System , Matrix Metalloproteinase 9/biosynthesis , Microfilament Proteins/biosynthesis , ras-GRF1/metabolism , Carcinogens/pharmacology , Cell Line, Tumor , Cell Movement/drug effects , Down-Regulation/drug effects , Filamins , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , MAP Kinase Signaling System/drug effects , Matrix Metalloproteinase 2/biosynthesis , Melanoma , Proto-Oncogene Proteins p21(ras)/metabolism , Tetradecanoylphorbol Acetate/pharmacology
6.
J Biol Chem ; 281(42): 31369-79, 2006 Oct 20.
Article in English | MEDLINE | ID: mdl-16926159

ABSTRACT

Interleukin (IL)-6 is a proinflammatory cytokine that has been implicated in the expression of acute phase plasma proteins and hepatic insulin resistance through activation of the JAK/STAT3 pathway. Although previous studies have demonstrated that pyrrolidine dithiocarbamate (PDTC) exerts protection against inflammatory responses, its role in the regulation of IL-6 receptor signaling remains unclear. Here we show that treatment of cultured HepG2 hepatoma cells with PDTC inhibits IL-6-stimulated tyrosine phosphorylation and subsequent nuclear translocation of STAT3 in a dose- and time-dependent fashion. No inhibition of JAK-1 activity was observed. To provide insight into PDTC signaling, we constructed a conditionally active STAT3 by fusing it with the ligand binding domain of the estrogen receptor (STAT3-ER). In the presence of 4-hydroxytamoxifen STAT3-ER was translocated in the nucleus of HepG2 cells in a phosphorylation-independent manner, and treatment with PDTC mitigated the response. Although STAT3 coprecipitated with heat-shock protein 90 (Hsp90) in control cells, coprecipitation of the two proteins was greatly reduced after PDTC treatment or after exposure to geldanamycin, an Hsp90 inhibitor. As a result there was a decrease in IL-6-induced association of STAT3 with the transcriptional coactivators FOXO1a and C/EBPbeta together with significant reduction in the expression of SOCS-3 protein and that of two major acute phase plasma proteins. Importantly, treatment of HepG2 cells and a primary culture of rat hepatocytes with PDTC restored insulin responsiveness that was abrogated by IL-6. These studies are consistent with the ability of PDTC to down-regulate IL-6-induced STAT3 activation by altering the stability of STAT3-Hsp90 complex.


Subject(s)
Hepatocytes/metabolism , Interleukin-6/metabolism , Pyrrolidines/pharmacology , STAT3 Transcription Factor/metabolism , Signal Transduction , Thiocarbamates/pharmacology , Active Transport, Cell Nucleus , Antioxidants/pharmacology , Cell Nucleus/metabolism , Chloramphenicol O-Acetyltransferase/metabolism , Down-Regulation , HSP90 Heat-Shock Proteins/metabolism , Humans , Tamoxifen/analogs & derivatives , Tamoxifen/pharmacology , Transcriptional Activation
7.
J Biol Chem ; 281(5): 2551-61, 2006 Feb 03.
Article in English | MEDLINE | ID: mdl-16319058

ABSTRACT

IkappaB kinase (IKK) catalytic subunits play a key role in cytokinemediated nuclear factor (NF)-kappaB signaling, and a loss of NF-kappaB function appears to inhibit inflammation and oncogenesis. Manumycin A is a potent and selective farnesyltransferase inhibitor with antitumor activity. We found that manumycin A caused a rapid and potent inhibition of IKK activity induced by tumor necrosis factor alpha in a number of cell types. Most unexpectedly, other classes of farnesyltransferase inhibitors had no inhibitory effect. To identify the molecular mechanisms of manumycin A action, cultured human HepG2 hepatoma cells were transiently transfected with various IKKalpha and IKKbeta constructs, and a striking difference in manumycin A sensitivity was observed. Furthermore, cells expressing wild-type IKKbeta and IKKbeta mutated in the activation loop at Cys-179 exhibited covalent homotypic dimerization of IKKbeta in response to manumycin A, whereas substitution of Cys-662 and -716 conferred protection against dimer formation. Direct inhibition of IKK activity and formation of stable IKKbeta dimers were observed in the presence of manumycin A that could be blocked by dithiothreitol. IKK interaction with the adaptor protein IKKgamma/NEMO was disrupted in manumycin A-treated cells. Most importantly, administration of manumycin A to mice xenografted with murine B16F10 tumors caused potent IKK-suppressive effects. Thus, manumycin A with its epoxyquinoid moieties plays an important regulatory function in IKK signaling through pathways distinct from its role as a protein farnesylation inhibitor.


Subject(s)
I-kappa B Kinase/antagonists & inhibitors , Polyenes/pharmacology , Amino Acid Substitution , Animals , Cell Line, Tumor , Dimerization , Humans , I-kappa B Kinase/genetics , Mice , Neoplasms, Experimental/drug therapy , Polyenes/therapeutic use , Polyunsaturated Alkamides , Protein Binding , Transfection , Tumor Necrosis Factor-alpha/pharmacology
8.
J Cell Biol ; 163(2): 375-84, 2003 Oct 27.
Article in English | MEDLINE | ID: mdl-14568990

ABSTRACT

A thiol-reactive membrane-associated protein (TRAP) binds covalently to the cytoplasmic domain of the human insulin receptor (IR) beta-subunit when cells are treated with the homobifunctional cross-linker reagent 1,6-bismaleimidohexane. Here, TRAP was found to be phospholipase C gamma1 (PLCgamma1) by mass spectrometry analysis. PLCgamma1 associated with the IR both in cultured cell lines and in a primary culture of rat hepatocytes. Insulin increased PLCgamma1 tyrosine phosphorylation at Tyr-783 and its colocalization with the IR in punctated structures enriched in cortical actin at the dorsal plasma membrane. This association was found to be independent of PLCgamma1 Src homology 2 domains, and instead required the pleckstrin homology (PH)-EF-hand domain. Expression of the PH-EF construct blocked endogenous PLCgamma1 binding to the IR and inhibited insulin-dependent phosphorylation of mitogen-activated protein kinase (MAPK), but not AKT. Silencing PLCgamma1 expression using small interfering RNA markedly reduced insulin-dependent MAPK regulation in HepG2 cells. Conversely, reconstitution of PLCgamma1 in PLCgamma1-/- fibroblasts improved MAPK activation by insulin. Our results show that PLCgamma1 is a thiol-reactive protein whose association with the IR could contribute to the activation of MAPK signaling by insulin.


Subject(s)
Blood Proteins/metabolism , Phosphoproteins/metabolism , Receptor, Insulin/metabolism , Type C Phospholipases/chemistry , Type C Phospholipases/metabolism , Animals , Blood Platelets/metabolism , CHO Cells , Cell Membrane/metabolism , Cells, Cultured , Cricetinae , Cross-Linking Reagents/pharmacology , Enzyme Activation , Fibroblasts/enzymology , Fibroblasts/metabolism , Hepatocytes/metabolism , Humans , Insulin/pharmacology , Male , Maleimides/pharmacology , Mice , Mice, Knockout , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Molecular Weight , Phospholipase C gamma , Phosphorylation , RNA, Small Interfering/pharmacology , Rats , Rats, Inbred F344 , Receptor, Insulin/antagonists & inhibitors , Type C Phospholipases/drug effects , Type C Phospholipases/isolation & purification
9.
J Biol Chem ; 278(29): 27096-104, 2003 Jul 18.
Article in English | MEDLINE | ID: mdl-12734206

ABSTRACT

The biological actions of insulin are associated with a rapid reorganization of the actin cytoskeleton within cells in culture. Even though this event requires the participation of actin-binding proteins, the effect of filamin A (FLNa) on insulin-mediated signaling events is still unknown. We report here that human melanoma M2 cells lacking FLNa expression exhibited normal insulin receptor (IR) signaling, whereas FLNa-expressing A7 cells were unable to elicit insulin-dependent Shc tyrosine phosphorylation and p42/44 MAPK activation despite no significant defect in IR-stimulated phosphorylation of insulin receptor substrate-1 or activation of the phosphatidylinositol 3-kinase/AKT cascade. Insulin-dependent translocation of Shc, SOS1, and MAPK to lipid raft microdomains was markedly attenuated by FLNa expression. Coimmunoprecipitation experiments and in vitro binding assays demonstrated that FLNa binds constitutively to IR and that neither insulin nor depolymerization of actin by cytochalasin D affected this interaction. The colocalization of endogenous FLNa with IR was detected at the surface of HepG2 cells. Ectopic expression of a C-terminal fragment of FLNa (FLNaCT) in HepG2 cells blocked the endogenous IR-FLNa interaction and potentiated insulin-stimulated MAPK phosphorylation and transactivation of Elk-1 compared with vector-transfected cells. Expression of FLNaCT had no major effect on insulin-induced phosphorylation of the IR, insulin receptor substrate-1, or AKT, but it elicited changes in actin cytoskeletal structure and ruffle formation in HepG2 cells. Taken together, these results indicate that FLNa interacts constitutively with the IR to exert an inhibitory tone along the MAPK activation pathway.


Subject(s)
Contractile Proteins/metabolism , DNA-Binding Proteins , Insulin/metabolism , MAP Kinase Signaling System/physiology , Microfilament Proteins/metabolism , Receptor, Insulin/metabolism , Transcription Factors , Base Sequence , Cell Line , Contractile Proteins/chemistry , Contractile Proteins/genetics , DNA/genetics , Filamins , Humans , In Vitro Techniques , Insulin Receptor Substrate Proteins , Membrane Microdomains/metabolism , Microfilament Proteins/chemistry , Microfilament Proteins/genetics , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Phosphoproteins/metabolism , Phosphorylation , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Receptor, Insulin/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Subcellular Fractions/metabolism , Transcriptional Activation , Transfection , ets-Domain Protein Elk-1
SELECTION OF CITATIONS
SEARCH DETAIL
...